Meridian Bioscience (VIVO) Releases Quarterly Earnings Results, Hits Estimates
Meridian Bioscience (NASDAQ:VIVO) released its earnings data on Wednesday. The company reported $0.18 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.18, American Banking and Market News reports. The company had revenue of $44.80 million for the quarter, compared to the consensus estimate of $47.59 million.
Shares of Meridian Bioscience (NASDAQ:VIVO) opened at 26.28 on Wednesday. Meridian Bioscience has a one year low of $19.15 and a one year high of $27.72. The stock has a 50-day moving average of $25.75 and a 200-day moving average of $24.27. The company has a market cap of $1.091 billion and a price-to-earnings ratio of 28.70.
Meridian Bioscience, Inc (NASDAQ:VIVO) is a fully-integrated life science company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.